Rickert Christian H, Paulus Werner
Institute of Pathology, University Hospital Münster, Domagkstrasse 17, 48149 Münster, Germany.
Childs Nerv Syst. 2004 Apr;20(4):221-4. doi: 10.1007/s00381-003-0909-8. Epub 2004 Feb 4.
Atypical teratoid/rhabdoid tumours (AT/RT) are highly malignant embryonal tumours of the brain composed of rhabdoid cells. Inactivating mutations of the hSNF5/INI-1 gene located in the chromosomal region 22q11.2 are regarded as a crucial step in their molecular pathogenesis. Apart from monosomy or deletions of chromosome 22 not much data exists on additional chromosomal aberrations.
We investigated seven primary AT/RT by comparative genomic hybridisation (CGH) and found DNA copy number changes in each case.
These consisted of loss of 22q in 7 out of 7 (100%) and loss of 19 in 3 out of 7 (43%) patients. In 4/7 AT/RT (57%), loss of chromosome 22q was the sole aberration whereas one patient showed additional losses of 16p, 17p and 20q.
Our CGH data suggest that apart from monosomy 22 additional genetic pathways may seem feasible for a subset of AT/RT that is yet to be defined. Furthermore, this study also emphasises the potential practical value of loss of chromosome 22 as a diagnostic marker for AT/RT.
非典型畸胎样/横纹肌样肿瘤(AT/RT)是由横纹肌样细胞构成的高度恶性的脑胚胎性肿瘤。位于染色体区域22q11.2的hSNF5/INI-1基因的失活突变被认为是其分子发病机制中的关键步骤。除了22号染色体单体或缺失外,关于其他染色体畸变的数据不多。
我们通过比较基因组杂交(CGH)研究了7例原发性AT/RT,发现每例均有DNA拷贝数变化。
这些变化包括7例中的7例(100%)出现22q缺失,7例中的3例(43%)出现19号染色体缺失。在4/7例AT/RT(57%)中,22号染色体q缺失是唯一的畸变,而1例患者还出现了16p、17p和20q的额外缺失。
我们的CGH数据表明,除了22号染色体单体缺失外,对于尚未明确的一部分AT/RT,其他遗传途径可能也是可行的。此外,本研究还强调了22号染色体缺失作为AT/RT诊断标志物的潜在实用价值。